邱明丰 - 上海交通大学

研究领域

1、生物仿生膜系统载药（天然药物、生物大分子、化学药物）研究 2、中药、民族药、天然药物物质基础及新药研究 3、可降解药用材料及其功能化研究

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

The in vivo and in vitro study of polysaccharides from a two-herb formula on ulcerative colitis and potential mechanism of action[J]. Journal of Ethnopharmacology, Volume 153, Issue 1, 11 April 2014, Pages 151-159. (IF2.939, 2014) Metabonomic strategy to study the evaluation of Chinese Medicine Compound Danshen Dripping Pills interfering myocardial ischemia in rats[J]. Evidence-Based Complementary and Alternative Medicine. Volume 2013, Article ID 718305, 10 pages.(IF2.175, 2014) Delivery of therapeutic AGT shRNA by PEG-Bu for hypertension therapy[J].PloS ONE,2013,7(8),e68651. (IF3.534, 2014) Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, lowcytotoxicity, and high efficiency for gene delivery[J]. International Journal of Nanomedicine. 2012,7, 693–704. (IF4.198, 2014) Biscarbamate cross-linked low molecular weight PEI for delivering IL-1 receptor antagonist gene to synoviocytes for arthritis therapy[J].Biomaterials. 2012, 33, 6520-6532. (IF8.312, 2013) Metabolic fate of tea polyphenols in Humans[J].J. Proteome Res. 2012, 11,3449-3457. (IF5.001, 2014) Characterization of Pu-erh tea using chemical and metabolic profiling approaches[J]. J. Agric .Food Chem. 2009, 57(8): 3046-3054. (IF3.107, 2014)